Oclacitinib txiv neej 1208319-27-0 Anti-inflammatory NSAID
Kev Them Nyiaj:T / T, L / C
Khoom Keeb Kwm:Tuam Tshoj
Shipping Chaw nres nkoj:Beijing / Shanghai / Hangzhou
Kev txiav txim (MOQ):10g ua
Lub Sijhawm Lead:3 hnub ua haujlwm
Muaj peev xwm ntau lawm:5 kg / hli
Kev cia khoom:Khaws rau hauv qhov chaw txias, qhuav, chav sov.
Cov khoom siv pob:vial
Pob loj:10g / vial
Cov ntaub ntawv kev nyab xeeb:Tsis yog khoom txaus ntshai
Taw qhia
Oclacitinib, yog ib qho tshuaj kho tsiaj siv los tswj cov kab mob atopic dermatitis thiab pruritus los ntawm kev ua xua dermatitis hauv dev tsawg kawg yog 12 lub hlis.Chemically, nws yog ib qho hluavtaws cyclohexylamino pyrrolopyrimidine janus kinase inhibitor uas yog xaiv rau JAK1.Nws inhibits lub teeb liab hloov thaum lub JAK tau qhib thiab yog li pab txo qis kev qhia ntawm inflammatory cytokines.
Oclacitinib tau sau npe los kho cov kab mob atopic dermatitis thiab khaus (pruritus) los ntawm kev ua xua hauv dev, txawm hais tias nws kuj tau siv los txo qhov khaus thiab dermatitis los ntawm flea infestations.Nws raug suav hais tias yog qhov ua tau zoo hauv cov dev, thiab tau tsim kom muaj kev nyab xeeb rau kev siv sijhawm luv luv.
Specification (hauv tsev qauv)
| Yam khoom | Specification |
| Qhov tshwm sim | Dawb khoom |
| HNMR | Ua raws li tus qauv |
| LC-MS | Ua raws li tus qauv |
| Purity | ≥98% |
| Melting point | N/A |
